{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:11:00Z","timestamp":1792188660753,"version":"4.4.0"},"reference-count":24,"publisher":"Media Sphere Publishing Group","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vestn. oftal'mol."],"published-print":{"date-parts":[[2019]]},"DOI":"10.17116\/oftalma201913503120","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T12:48:58Z","timestamp":1565268538000},"page":"20","source":"Crossref","is-referenced-by-count":9,"title":["Structural and functional changes in the retina of patients with primary open-angle glaucoma and compensated intraocular pressure while undergoing retinoprotective therapy"],"prefix":"10.17116","volume":"135","author":[{"given":"E. A.","family":"Egorov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. P.","family":"Erichev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. V.","family":"Strakhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Yu.","family":"Petrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. B.","family":"Romanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. V.","family":"Vasina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. S.","family":"Zinina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Makarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Yu.","family":"Kazanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. V.","family":"Yartsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6743","reference":[{"key":"key-10.17116\/oftalma201913503120-1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.081224"},{"key":"key-10.17116\/oftalma201913503120-2","unstructured":"Resnikoff S, Pascolini D, Etya'ale D, Kocur I, et al. Global data on visual impairment in the year 2002. Bulletin of the World Health Organization. 2004;82(11):844-851."},{"key":"key-10.17116\/oftalma201913503120-3","doi-asserted-by":"crossref","unstructured":"Osborne NN, Chidlow G, Wood J, Casson R. Some current ideas on the pathogenesis and the role of neuroprotection in glaucomatous optic neuropathy. European journal of ophthalmology. 2003;13(suppl 3):19-26.","DOI":"10.1177\/112067210301303S04"},{"key":"key-10.17116\/oftalma201913503120-4","doi-asserted-by":"crossref","unstructured":"Bonomi L. Epidemiology of angle-closure glaucoma. Acta ophthalmologica Scandinavica Supplement. 2002;236:11-13.","DOI":"10.1034\/j.1600-0420.80.s236.2.x"},{"key":"key-10.17116\/oftalma201913503120-5","doi-asserted-by":"crossref","unstructured":"Tielsch JM, Sommer A, Katz J, Royall RM, et al. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. Jama. 1991;266(3):369-374.","DOI":"10.1001\/jama.1991.03470030069026"},{"key":"key-10.17116\/oftalma201913503120-6","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.4.532"},{"key":"key-10.17116\/oftalma201913503120-7","doi-asserted-by":"publisher","DOI":"10.1038\/nrg1578"},{"key":"key-10.17116\/oftalma201913503120-8","doi-asserted-by":"crossref","unstructured":"Anderson DR, Drance SM, Schulzer M. Collaborative Normal-Tension Glaucoma Study G. Factors that predict the benefit of lowering intraocular pressure in normal tension glaucoma. American journal of ophthalmology. 2003;136(5):820-829.","DOI":"10.1016\/S0002-9394(03)00478-1"},{"key":"key-10.17116\/oftalma201913503120-9","doi-asserted-by":"crossref","unstructured":"Armaly MF, Krueger DE, Maunder L, Becker B, et al. Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects. Archives of ophthalmology. 1980;98(12):2163-2171.","DOI":"10.1001\/archopht.1980.01020041015002"},{"key":"key-10.17116\/oftalma201913503120-10","doi-asserted-by":"crossref","unstructured":"Heijl A, Leske MC, Bengtsson B, Hyman L, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Archives of ophthalmology. 2002;120(10):1268-1279.","DOI":"10.1001\/archopht.120.10.1268"},{"key":"key-10.17116\/oftalma201913503120-11","doi-asserted-by":"crossref","unstructured":"Brubaker RF. Delayed functional loss in glaucoma. LII Edward Jackson Memorial Lecture. American journal of ophthalmology. 1996;121(5):473-483.","DOI":"10.1016\/S0002-9394(14)75421-2"},{"key":"key-10.17116\/oftalma201913503120-12","doi-asserted-by":"crossref","unstructured":"Cockburn DM. Does reduction of intraocular pressure (IOP) prevent visual field loss in glaucoma? American journal of optometry and physiological optics. 1983;60(8):705-711.","DOI":"10.1097\/00006324-198308000-00009"},{"key":"key-10.17116\/oftalma201913503120-13","doi-asserted-by":"crossref","unstructured":"Levin LA. Direct and indirect approaches to neuroprotective therapy of glaucomatous optic neuropathy. Survey of ophthalmology. 1999;43(suppl 1):98-101.","DOI":"10.1016\/S0039-6257(99)00027-2"},{"key":"key-10.17116\/oftalma201913503120-14","unstructured":"Neacsu A, Oprean C, Curea M, Tuchila G, et al. Neuroprotection with carotenoids in glaucoma. Oftalmologia. 2003;59(4):70-75."},{"key":"key-10.17116\/oftalma201913503120-15","doi-asserted-by":"crossref","unstructured":"Neufeld AH. New conceptual approaches for pharmacological neuroprotection in glaucomatous neuronal degeneration. Journal of glaucoma. 1998;7(6):434-438.","DOI":"10.1097\/00061198-199812000-00014"},{"key":"key-10.17116\/oftalma201913503120-16","doi-asserted-by":"crossref","unstructured":"Weinreb RN, Levin LA. Is neuroprotection a viable therapy for glaucoma? Archives of ophthalmology. 1999;117(11):1540-1544.","DOI":"10.1001\/archopht.117.11.1540"},{"key":"key-10.17116\/oftalma201913503120-17","unstructured":"Abizgyldina GSh. Experience of glaucomatous optic neuropathy combined treatment. Meditsinskiy vestnik Bashkortostana. 2014;9(2):15-18. (In Russ.)"},{"key":"key-10.17116\/oftalma201913503120-18","unstructured":"Alekseev VN, Sadkov VI, Aksenova AL, Shasha D. Neiroprotektsiya pri POUG. V sbornike: pod red. Nesterov A.P. i dr. Glaukoma: teorii, tendentsii, tekhnologii: materialy VI Mezhdunarodnoi konferentsii, Moskva, 5 dekabrya 2008;31-45. (In Russ.)"},{"key":"key-10.17116\/oftalma201913503120-19","unstructured":"Astakhov YuS, Butin EV, Morozova NV, Sokolov VO. Results of Retinalamin use in patients with primary open-angle glaucoma. Glaukoma. 2006;2:43-47. (In Russ.)"},{"key":"key-10.17116\/oftalma201913503120-20","unstructured":"Egorov EA, Egorova TE, Shramko YuG. Efficacy of Retinalamin use in patients with compensated primary open-angle glaucoma. RMJ Klinicheskaya Oftalmologiya. 2014;15(4):188-193. (In Russ.)"},{"key":"key-10.17116\/oftalma201913503120-21","unstructured":"Ilyina SN, Lomanik IF, Logosh SM, Shavlovskaya TV. Retinalamin in neuroprotective therapy of primary open-angle glaucoma patients. Ofthalmologiya Vostochnaya Evropa. 2012;15(4):96-101. (In Russ.)"},{"key":"key-10.17116\/oftalma201913503120-22","unstructured":"Mazunin IYu. Results of 'Retinalamin' neuroprotector use after laser trabeculoplasty in compensated primary open-angle glaucoma treatment. Meditsinskiy almanakh. 2014;31(1):69-73. (In Russ.)"},{"key":"key-10.17116\/oftalma201913503120-23","unstructured":"Malyshevskaya TN, Dolgova IG. Comparative effectiveness analysis of different methods of neuroprotective therapy in patients with non-progressive advanced primary glaucoma. Natsional'nyi zhurnal glaukoma. 2016;15(2):84-92. (In Russ.)"},{"key":"key-10.17116\/oftalma201913503120-24","doi-asserted-by":"crossref","unstructured":"Rozhko YuI, Marchenko LN, Rebenok NA, Krivun AO. et al. Neuroprotective action of Cortexin and Retinalamin in primary open-angle glaucoma treatment. Problemy zdorovia i ekologii. 2010;25(3):50-55. (In Russ.)","DOI":"10.51523\/2708-6011.2010-7-3-9"}],"container-title":["Vestnik oftal'mologii"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T22:58:36Z","timestamp":1695077916000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/vestnik-oftalmologii\/2019\/3\/downloads\/ru\/10042465X2019031020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"alternative-id":["oftalma201913503120"],"URL":"https:\/\/doi.org\/10.17116\/oftalma201913503120","relation":{},"ISSN":["0042-465X"],"issn-type":[{"value":"0042-465X","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}